Top Markets
#1 Black Phoenix Black Phoenix +167.48%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +43.60%
#5 Cryptopia Cryptopia +20.92%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.51%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.45%
#8 Test Test +17.66%
#9 Victoria VR Victoria VR +12.65%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +10.37%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
GeneLink, Inc. GeneLink, Inc.

GeneLink, Inc.

GNLKQ
Rank in Stocks #41769
GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond... GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.
Share Price
$0.00004
Last synced: 2026-08-11
Market Cap
$10.60K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade GeneLink, Inc. (GNLKQ)

Category

Healthcare
Revenue for GeneLink, Inc. (GNLKQ)
Revenue in Aug 2026 TTM: 0
According to GeneLink, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GeneLink, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR